Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Regulation of Mitochondria-Associated Membranes (MAMs) by NO/sGC/PKG Participates in the Control of Hepatic Insulin Response.

Bassot A, Chauvin MA, Bendridi N, Ji-Cao J, Vial G, Monnier L, Bartosch B, Alves A, Cottet-Rousselle C, Gouriou Y, Rieusset J, Morio B.

Cells. 2019 Oct 25;8(11). pii: E1319. doi: 10.3390/cells8111319.

PMID:
31731523
2.

Hepatitis C Virus RNA-Dependent RNA Polymerase Is Regulated by Cysteine S-Glutathionylation.

Kukhanova MK, Tunitskaya VL, Smirnova OA, Khomich OA, Zakirova NF, Ivanova ON, Ziganshin R, Bartosch B, Kochetkov SN, Ivanov AV.

Oxid Med Cell Longev. 2019 Sep 3;2019:3196140. doi: 10.1155/2019/3196140. eCollection 2019.

3.

Two phase kinetics of the inflammatory response from hepatocyte-peripheral blood mononuclear cell interactions.

Beringer A, Molle J, Bartosch B, Miossec P.

Sci Rep. 2019 Jun 10;9(1):8378. doi: 10.1038/s41598-019-44840-w.

4.

Activation of Polyamine Catabolism by N¹,N11-Diethylnorspermine in Hepatic HepaRG Cells Induces Dedifferentiation and Mesenchymal-Like Phenotype.

Ivanova ON, Snezhkina AV, Krasnov GS, Valuev-Elliston VT, Khomich OA, Khomutov AR, Keinanen TA, Alhonen L, Bartosch B, Kudryavtseva AV, Kochetkov SN, Ivanov AV.

Cells. 2018 Dec 18;7(12). pii: E275. doi: 10.3390/cells7120275.

5.

Redox Biology of Respiratory Viral Infections.

Khomich OA, Kochetkov SN, Bartosch B, Ivanov AV.

Viruses. 2018 Jul 26;10(8). pii: E392. doi: 10.3390/v10080392. Review.

6.

Synergistic effect of interleukin-17 and tumour necrosis factor-α on inflammatory response in hepatocytes through interleukin-6-dependent and independent pathways.

Beringer A, Thiam N, Molle J, Bartosch B, Miossec P.

Clin Exp Immunol. 2018 Aug;193(2):221-233. doi: 10.1111/cei.13140. Epub 2018 May 31.

7.

Polyamine Metabolism and Oxidative Protein Folding in the ER as ROS-Producing Systems Neglected in Virology.

Smirnova OA, Bartosch B, Zakirova NF, Kochetkov SN, Ivanov AV.

Int J Mol Sci. 2018 Apr 17;19(4). pii: E1219. doi: 10.3390/ijms19041219. Review.

8.

CD81 large extracellular loop-containing fusion proteins with a dominant negative effect on HCV cell spread and replication.

Grigorov B, Molle J, Rubinstein E, Zoulim F, Bartosch B.

J Gen Virol. 2017 Jul;98(7):1646-1657. doi: 10.1099/jgv.0.000850. Epub 2017 Jul 19.

PMID:
28721844
9.

Oxidative Stress in Infection and Consequent Disease.

Ivanov AV, Bartosch B, Isaguliants MG.

Oxid Med Cell Longev. 2017;2017:3496043. doi: 10.1155/2017/3496043. Epub 2017 Feb 1. No abstract available.

10.

Hepatitis C virus alters metabolism of biogenic polyamines by affecting expression of key enzymes of their metabolism.

Smirnova OA, Keinanen TA, Ivanova ON, Hyvonen MT, Khomutov AR, Kochetkov SN, Bartosch B, Ivanov AV.

Biochem Biophys Res Commun. 2017 Feb 5;483(2):904-909. doi: 10.1016/j.bbrc.2017.01.032. Epub 2017 Jan 9.

PMID:
28082202
11.

Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis.

Ivanov AV, Valuev-Elliston VT, Tyurina DA, Ivanova ON, Kochetkov SN, Bartosch B, Isaguliants MG.

Oncotarget. 2017 Jan 17;8(3):3895-3932. doi: 10.18632/oncotarget.13904. Review.

12.

Hepatitis C virus infection propagates through interactions between Syndecan-1 and CD81 and impacts the hepatocyte glycocalyx.

Grigorov B, Reungoat E, Gentil Dit Maurin A, Varbanov M, Blaising J, Michelet M, Manuel R, Parent R, Bartosch B, Zoulim F, Ruggiero F, Pécheur EI.

Cell Microbiol. 2017 May;19(5). doi: 10.1111/cmi.12711. Epub 2016 Dec 23.

PMID:
27930836
13.

Hepatitis C virus infection triggers a tumor-like glutamine metabolism.

Lévy PL, Duponchel S, Eischeid H, Molle J, Michelet M, Diserens G, Vermathen M, Vermathen P, Dufour JF, Dienes HP, Steffen HM, Odenthal M, Zoulim F, Bartosch B.

Hepatology. 2017 Mar;65(3):789-803. doi: 10.1002/hep.28949. Epub 2017 Feb 3.

14.

Oxidative Stress during HIV Infection: Mechanisms and Consequences.

Ivanov AV, Valuev-Elliston VT, Ivanova ON, Kochetkov SN, Starodubova ES, Bartosch B, Isaguliants MG.

Oxid Med Cell Longev. 2016;2016:8910396. Epub 2016 Oct 13. Review.

15.

Effect of Quercetin on Hepatitis C Virus Life Cycle: From Viral to Host Targets.

Rojas Á, Del Campo JA, Clement S, Lemasson M, García-Valdecasas M, Gil-Gómez A, Ranchal I, Bartosch B, Bautista JD, Rosenberg AR, Negro F, Romero-Gómez M.

Sci Rep. 2016 Aug 22;6:31777. doi: 10.1038/srep31777.

16.

T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates.

Rollier CS, Verschoor EJ, Verstrepen BE, Drexhage JA, Paranhos-Baccala G, Liljeström P, Sutter G, Arribillaga L, Lasarte JJ, Bartosch B, Cosset FL, Inchauspe G, Heeney JL.

Gene Ther. 2016 Oct;23(10):753-759. doi: 10.1038/gt.2016.55. Epub 2016 Jul 14.

PMID:
27416077
17.

Hepatitis C Virus NS5A Protein Triggers Oxidative Stress by Inducing NADPH Oxidases 1 and 4 and Cytochrome P450 2E1.

Smirnova OA, Ivanova ON, Bartosch B, Valuev-Elliston VT, Mukhtarov F, Kochetkov SN, Ivanov AV.

Oxid Med Cell Longev. 2016;2016:8341937. doi: 10.1155/2016/8341937. Epub 2016 Apr 20.

18.

Epidermal Growth Factor Receptor-Dependent Mutual Amplification between Netrin-1 and the Hepatitis C Virus.

Plissonnier ML, Lahlali T, Michelet M, Lebossé F, Cottarel J, Beer M, Neveu G, Durantel D, Bartosch B, Accardi R, Clément S, Paradisi A, Devouassoux-Shisheboran M, Einav S, Mehlen P, Zoulim F, Parent R.

PLoS Biol. 2016 Mar 31;14(3):e1002421. doi: 10.1371/journal.pbio.1002421. eCollection 2016 Mar.

19.

Hepatitis C Virus Increases Occludin Expression via the Upregulation of Adipose Differentiation-Related Protein.

Branche E, Conzelmann S, Parisot C, Bedert L, Lévy PL, Bartosch B, Clément S, Negro F.

PLoS One. 2016 Jan 5;11(1):e0146000. doi: 10.1371/journal.pone.0146000. eCollection 2016.

20.

Metabolic reprogramming: a hallmark of viral oncogenesis.

Lévy P, Bartosch B.

Oncogene. 2016 Aug 11;35(32):4155-64. doi: 10.1038/onc.2015.479. Epub 2015 Dec 21. Review.

PMID:
26686092
21.

Disruption of calcium transfer from ER to mitochondria links alterations of mitochondria-associated ER membrane integrity to hepatic insulin resistance.

Rieusset J, Fauconnier J, Paillard M, Belaidi E, Tubbs E, Chauvin MA, Durand A, Bravard A, Teixeira G, Bartosch B, Michelet M, Theurey P, Vial G, Demion M, Blond E, Zoulim F, Gomez L, Vidal H, Lacampagne A, Ovize M.

Diabetologia. 2016 Mar;59(3):614-23. doi: 10.1007/s00125-015-3829-8. Epub 2015 Dec 10.

PMID:
26660890
22.

Hepatitis C Virus Envelope Glycoprotein E1 Forms Trimers at the Surface of the Virion.

Falson P, Bartosch B, Alsaleh K, Tews BA, Loquet A, Ciczora Y, Riva L, Montigny C, Montpellier C, Duverlie G, Pécheur EI, le Maire M, Cosset FL, Dubuisson J, Penin F.

J Virol. 2015 Oct;89(20):10333-46. doi: 10.1128/JVI.00991-15. Epub 2015 Aug 5.

23.

HCV core protein uses multiple mechanisms to induce oxidative stress in human hepatoma Huh7 cells.

Ivanov AV, Smirnova OA, Petrushanko IY, Ivanova ON, Karpenko IL, Alekseeva E, Sominskaya I, Makarov AA, Bartosch B, Kochetkov SN, Isaguliants MG.

Viruses. 2015 May 29;7(6):2745-70. doi: 10.3390/v7062745.

24.

Glutathione peroxidase 4 is reversibly induced by HCV to control lipid peroxidation and to increase virion infectivity.

Brault C, Lévy P, Duponchel S, Michelet M, Sallé A, Pécheur EI, Plissonnier ML, Parent R, Véricel E, Ivanov AV, Demir M, Steffen HM, Odenthal M, Zoulim F, Bartosch B.

Gut. 2016 Jan;65(1):144-54. doi: 10.1136/gutjnl-2014-307904. Epub 2014 Dec 16.

PMID:
25516417
25.

Piecing together the key players of fibrosis in chronic hepatitis C: what roles do non-hepatic liver resident cell types play?

Bartosch B.

Gut. 2015 Jun;64(6):862-3. doi: 10.1136/gutjnl-2014-307957. Epub 2014 Sep 8. No abstract available.

PMID:
25200745
26.

Mitochondria-associated endoplasmic reticulum membrane (MAM) integrity is required for insulin signaling and is implicated in hepatic insulin resistance.

Tubbs E, Theurey P, Vial G, Bendridi N, Bravard A, Chauvin MA, Ji-Cao J, Zoulim F, Bartosch B, Ovize M, Vidal H, Rieusset J.

Diabetes. 2014 Oct;63(10):3279-94. doi: 10.2337/db13-1751. Epub 2014 Jun 19.

27.

An immortalized human liver endothelial sinusoidal cell line for the study of the pathobiology of the liver endothelium.

Parent R, Durantel D, Lahlali T, Sallé A, Plissonnier ML, DaCosta D, Lesca G, Zoulim F, Marion MJ, Bartosch B.

Biochem Biophys Res Commun. 2014 Jul 18;450(1):7-12. doi: 10.1016/j.bbrc.2014.05.038. Epub 2014 May 20.

PMID:
24853805
28.

Batch profiling calibration for robust NMR metabonomic data analysis.

Fages A, Pontoizeau C, Jobard E, Lévy P, Bartosch B, Elena-Herrmann B.

Anal Bioanal Chem. 2013 Nov;405(27):8819-27. doi: 10.1007/s00216-013-7296-0. Epub 2013 Aug 24.

PMID:
23975089
29.

Role of seipin in lipid droplet morphology and hepatitis C virus life cycle.

Clément S, Fauvelle C, Branche E, Kaddai V, Conzelmann S, Boldanova T, Bartosch B, Minehira K, Negro F.

J Gen Virol. 2013 Oct;94(Pt 10):2208-14. doi: 10.1099/vir.0.054593-0. Epub 2013 Aug 1.

PMID:
23907395
30.

Hepatitis C virus-induced mitochondrial dysfunctions.

Brault C, Levy PL, Bartosch B.

Viruses. 2013 Mar 21;5(3):954-80. doi: 10.3390/v5030954. Review.

31.

Epstein - Barr virus transforming protein LMP-1 alters B cells gene expression by promoting accumulation of the oncoprotein ΔNp73α.

Accardi R, Fathallah I, Gruffat H, Mariggiò G, Le Calvez-Kelm F, Voegele C, Bartosch B, Hernandez-Vargas H, McKay J, Sylla BS, Manet E, Tommasino M.

PLoS Pathog. 2013 Mar;9(3):e1003186. doi: 10.1371/journal.ppat.1003186. Epub 2013 Mar 14.

32.

Very-low-density lipoprotein (VLDL)-producing and hepatitis C virus-replicating HepG2 cells secrete no more lipoviroparticles than VLDL-deficient Huh7.5 cells.

Jammart B, Michelet M, Pécheur EI, Parent R, Bartosch B, Zoulim F, Durantel D.

J Virol. 2013 May;87(9):5065-80. doi: 10.1128/JVI.01405-12. Epub 2013 Feb 20.

33.

HCV and oxidative stress in the liver.

Ivanov AV, Bartosch B, Smirnova OA, Isaguliants MG, Kochetkov SN.

Viruses. 2013 Jan 28;5(2):439-69. doi: 10.3390/v5020439. Review.

34.

The mouse IAPE endogenous retrovirus can infect cells through any of the five GPI-anchored Ephrin A proteins.

Dewannieux M, Vernochet C, Ribet D, Bartosch B, Cosset FL, Heidmann T.

PLoS Pathog. 2011 Oct;7(10):e1002309. doi: 10.1371/journal.ppat.1002309. Epub 2011 Oct 20.

35.

Hepatitis B and C viruses and hepatocellular carcinoma.

Bartosch B.

Viruses. 2010 Aug;2(8):1504-9. doi: 10.3390/v2081504. Epub 2010 Jul 27. No abstract available.

36.

Characterization of hepatitis C virus pseudoparticles by cryo-transmission electron microscopy using functionalized magnetic nanobeads.

Bonnafous P, Perrault M, Le Bihan O, Bartosch B, Lavillette D, Penin F, Lambert O, Pécheur EI.

J Gen Virol. 2010 Aug;91(Pt 8):1919-30. doi: 10.1099/vir.0.021071-0. Epub 2010 Apr 7.

PMID:
20375221
37.

Recent advances in hepatitis C virus cell entry.

Bartosch B, Dubuisson J.

Viruses. 2010 Mar;2(3):692-709. doi: 10.3390/v2030692. Epub 2010 Mar 8.

38.

The Ig domain protein CD9P-1 down-regulates CD81 ability to support Plasmodium yoelii infection.

Charrin S, Yalaoui S, Bartosch B, Cocquerel L, Franetich JF, Boucheix C, Mazier D, Rubinstein E, Silvie O.

J Biol Chem. 2009 Nov 13;284(46):31572-8. doi: 10.1074/jbc.M109.057927. Epub 2009 Sep 17.

39.

Hepatitis C virus-induced hepatocarcinogenesis.

Bartosch B, Thimme R, Blum HE, Zoulim F.

J Hepatol. 2009 Oct;51(4):810-20. doi: 10.1016/j.jhep.2009.05.008. Epub 2009 May 23. Review.

40.

The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection.

Benedicto I, Molina-Jiménez F, Bartosch B, Cosset FL, Lavillette D, Prieto J, Moreno-Otero R, Valenzuela-Fernández A, Aldabe R, López-Cabrera M, Majano PL.

J Virol. 2009 Aug;83(16):8012-20. doi: 10.1128/JVI.00038-09. Epub 2009 Jun 10.

41.

Hepatitis C virus and its complex interplay with hepatic glucose and lipid metabolism.

Bartosch B.

J Hepatol. 2009 May;50(5):845-7. doi: 10.1016/j.jhep.2009.02.009. Epub 2009 Mar 12. No abstract available.

42.

Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains.

Dreux M, Dao Thi VL, Fresquet J, Guérin M, Julia Z, Verney G, Durantel D, Zoulim F, Lavillette D, Cosset FL, Bartosch B.

PLoS Pathog. 2009 Feb;5(2):e1000310. doi: 10.1371/journal.ppat.1000310. Epub 2009 Feb 20.

43.

Porcine endogenous retroviruses PERV A and A/C recombinant are insensitive to a range of divergent mammalian TRIM5alpha proteins including human TRIM5alpha.

Wood A, Webb BL, Bartosch B, Schaller T, Takeuchi Y, Towers GJ.

J Gen Virol. 2009 Mar;90(Pt 3):702-9. doi: 10.1099/vir.0.007377-0.

44.

Characterization of Lassa virus cell entry and neutralization with Lassa virus pseudoparticles.

Cosset FL, Marianneau P, Verney G, Gallais F, Tordo N, Pécheur EI, ter Meulen J, Deubel V, Bartosch B.

J Virol. 2009 Apr;83(7):3228-37. doi: 10.1128/JVI.01711-08. Epub 2009 Jan 19.

45.

Studying HCV cell entry with HCV pseudoparticles (HCVpp).

Bartosch B, Cosset FL.

Methods Mol Biol. 2009;510:279-93. doi: 10.1007/978-1-59745-394-3_21.

PMID:
19009269
46.

The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus.

Dreux M, Boson B, Ricard-Blum S, Molle J, Lavillette D, Bartosch B, Pécheur EI, Cosset FL.

J Biol Chem. 2007 Nov 2;282(44):32357-69. Epub 2007 Aug 30.

47.

Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C.

Pestka JM, Zeisel MB, Bläser E, Schürmann P, Bartosch B, Cosset FL, Patel AH, Meisel H, Baumert J, Viazov S, Rispeter K, Blum HE, Roggendorf M, Baumert TF.

Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):6025-30. Epub 2007 Mar 28.

48.

Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitors.

Chapel C, Garcia C, Bartosch B, Roingeard P, Zitzmann N, Cosset FL, Dubuisson J, Dwek RA, Trépo C, Zoulim F, Durantel D.

J Gen Virol. 2007 Apr;88(Pt 4):1133-43.

PMID:
17374756
49.

Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity.

Rollier CS, Paranhos-Baccala G, Verschoor EJ, Verstrepen BE, Drexhage JA, Fagrouch Z, Berland JL, Komurian-Pradel F, Duverger B, Himoudi N, Staib C, Meyr M, Whelan M, Whelan JA, Adams VC, Larrea E, Riezu JI, Lasarte JJ, Bartosch B, Cosset FL, Spaan WJ, Diepolder HM, Pape GR, Sutter G, Inchauspe G, Heeney JL.

Hepatology. 2007 Mar;45(3):602-13. Erratum in: Hepatology. 2007 Jun;45(6):1590. Adams, Victoria A [corrected to Adams, Victoria C]; Lasarte, Juan José [corrected to Lasarte, Juan J].

PMID:
17326154
50.

Hepatitis C virus E2 links soluble human CD81 and SR-B1 protein.

Heo TH, Lee SM, Bartosch B, Cosset FL, Kang CY.

Virus Res. 2006 Oct;121(1):58-64. Epub 2006 May 24.

PMID:
16725222

Supplemental Content

Loading ...
Support Center